The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
KI intolerance study: A phase 2 study to assess the safety and efficacy of TGR-1202 in pts with chronic lymphocytic leukemia (CLL) who are intolerant to prior BTK or PI3K-delta inhibitor therapy.
 
Colleen Dorsey
Honoraria - Janssen; TG Therapeutics
Consulting or Advisory Role - TG Therapeutics
Travel, Accommodations, Expenses - Celgene; Genentech; ProNAi
 
Dana Paskalis
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Danielle M. Brander
Consulting or Advisory Role - Abbvie; Genentech; Gilead Sciences; Pharmacyclics; Teva
 
Frederick Lansigan
No Relationships to Disclose
 
Paul M. Barr
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Infinity Pharmaceuticals; Novartis; Pharmacyclics; Seagen
Research Funding - Pharmacyclics (Inst)
 
Nicole Lamanna
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Juno Therapeutics; pharmacyclics; ProNAi; Roche
Research Funding - Abbvie (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); ProNAi (Inst)
 
Bruce D. Cheson
Consulting or Advisory Role - Acerta Pharma; Pharmacyclics
Research Funding - Acerta Pharma (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Jeffrey J. Pu
No Relationships to Disclose
 
Marshall T. Schreeder
No Relationships to Disclose
 
John M. Pagel
Consulting or Advisory Role - Gilead Sciences; Pharmacyclics
 
Peter Sportelli
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Molly J Fanning
No Relationships to Disclose
 
Hari P. Miskin
Employment - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Tracey Zimmer
No Relationships to Disclose
 
Kristy Walsh
No Relationships to Disclose
 
Stephen J. Schuster
Consulting or Advisory Role - Celgene; Gilead Sciences; Nordic Nanovector; Novartis; Pharmacyclics
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Johnson & Johnson (Inst); Novartis (Inst); Pharmacyclics (Inst)
 
Eline T. Luning-Prak
Research Funding - Biogen (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Janssen (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
E. Paul Wileyto
No Relationships to Disclose
 
Michael S. Weiss
No Relationships to Disclose
 
Anthony R. Mato
Consulting or Advisory Role - Celgene; Genentech; Gilead Sciences; Pharmacyclics; Regeneron
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); DTRM (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); Regeneron (Inst); TG Therapeutics (Inst)